etoposide and Rhabdomyosarcoma, Alveolar
etoposide has been researched along with Rhabdomyosarcoma, Alveolar in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ebinger, M; Fuchs, J; Heinz, AT; Juntti, H; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, M; Pajtler, KW; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T | 1 |
Kajita, N; Makimoto, A; Miyahara, S; Saito, Y; Yuza, Y | 1 |
Pappo, A; Paulino, AC | 1 |
Asea, A; Boos, J; Borkhardt, A; Dantonello, T; Hoehn, T; Klee, D; Koscielniak, E; Krefeld, B; Siepermann, M; Wessalowski, R | 1 |
Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB | 1 |
Chen, KT | 1 |
Donaldson, SS; Ensign, LG; Heyn, R; Khan, F; Maurer, HM; Ruymann, F; Smith, MA; Vietti, T | 1 |
Castello, MA; Gauthier, F; Oberlin, O; Schiavetti, A | 1 |
Felgenhauer, J; Hawkins, D; Radich, J; Thomson, B | 1 |
Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
Reviews
1 review(s) available for etoposide and Rhabdomyosarcoma, Alveolar
Article | Year |
---|---|
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Trials
1 trial(s) available for etoposide and Rhabdomyosarcoma, Alveolar
Article | Year |
---|---|
Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Extremities; Family Health; Female; Humans; Infant; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Meningeal Neoplasms; Myelodysplastic Syndromes; Neoplasms, Second Primary; Odds Ratio; Osteosarcoma; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Risk Factors; Spinal Neoplasms | 1994 |
Other Studies
8 other study(ies) available for etoposide and Rhabdomyosarcoma, Alveolar
Article | Year |
---|---|
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Etoposide; Humans; Registries; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Risk Factors; Sarcoma; Soft Tissue Neoplasms | 2024 |
Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Ifosfamide; Japan; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Rhabdomyosarcoma, Alveolar | 2020 |
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine | 2009 |
Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Rhabdomyosarcoma, Alveolar | 2012 |
Rhabdomyosarcoma in an adult presenting with nodal metastasis: a pitfall in fine-needle aspiration cytology of lymph nodes.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymph Nodes; Lymphatic Metastasis; Paranasal Sinus Neoplasms; Radiotherapy; Rhabdomyosarcoma, Alveolar; Tomography, X-Ray Computed | 2005 |
Long-lasting complete remission after prolonged administration of etoposide in a child with a second recurrence of alveolar rhabdomyosarcoma.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Remission Induction; Rhabdomyosarcoma, Alveolar; Thigh; Time Factors | 1997 |
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Purging; Bone Neoplasms; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 22; Combined Modality Therapy; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Mesna; Neoplasm Proteins; Neoplastic Cells, Circulating; Oncogene Proteins, Fusion; Paired Box Transcription Factors; PAX3 Transcription Factor; Proto-Oncogene Protein c-fli-1; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma, Alveolar; RNA-Binding Protein EWS; Sarcoma, Ewing; Sensitivity and Specificity; Soft Tissue Neoplasms; Transcription Factors; Translocation, Genetic; Vincristine | 1999 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |